Michael S. Hofman
Impact in
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 169
- Prostate Cancer Diagnosis and Treatment 66
-
- Radiopharmaceutical Chemistry and Applications 143
- Medical Imaging Techniques and Applications 75
- Radiomics and Machine Learning in Medical Imaging 32
- Co-authors
- Rodney J. Hicks (110 shared papers)Declan G. Murphy (60 shared papers)Grace Kong (46 shared papers)Nathan Lawrentschuk (33 shared papers)Amir Iravani (48 shared papers)Peter Eu (24 shared papers)Price Jackson (35 shared papers)Marlon Perera (11 shared papers)
- Journals
- Journal of Clinical Oncology (43 papers)Journal of Nuclear Medicine (40 papers)European Journal of Nuclear Medicine and Molecular Imaging (22 papers)European Urology (17 papers)British Journal of Urology (15 papers)
- Partner nations
- AustraliaUnited StatesGermany
In The Last Decade
Michael S. Hofman
308 papers receiving 11.5k citations
Michael S. Hofman's Hit Papers
Peers
Comparison fields: 5 of 149
- Radiology, Nuclear Medicine and Imaging 6.5k
- Pulmonary and Respiratory Medicine 7.1k
- Oncology 3.0k
- Radiation 878
- Neurology 1.3k
Countries citing papers authored by Michael S. Hofman
This map shows the geographic impact of Michael S. Hofman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Hofman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Hofman more than expected).
Fields of papers citing papers by Michael S. Hofman
This network shows the impact of papers produced by Michael S. Hofman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Hofman. The network helps show where Michael S. Hofman may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael S. Hofman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 325 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study Hit paper breakdown → | 2018 | 815 |
| 2 | Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis Hit paper breakdown → | 2016 | 744 |
| 3 | Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis Hit paper breakdown → | 2019 | 621 |
| 4 | Somatostatin Receptor Imaging with68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation Hit paper breakdown → | 2015 | 383 |
| 5 | Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes Hit paper breakdown → | 2018 | 339 |
| 6 | Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls Hit paper breakdown → | 2018 | 266 |
| 7 | Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial Hit paper breakdown → | 2018 | 222 |
| 8 | E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET Hit paper breakdown → | 2021 | 214 |
| 9 | 2012 | 201 | |
| 10 | 2013 | 191 | |
| 11 | 2019 | 183 | |
| 12 | 2017 | 178 | |
| 13 | 2018 | 129 | |
| 14 | Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2) Hit paper breakdown → | 2023 | 127 |
| 15 | 2016 | 126 | |
| 16 | 2012 | 123 | |
| 17 | 2003 | 120 | |
| 18 | 2017 | 119 | |
| 19 | 2020 | 115 | |
| 20 | 2011 | 111 |
About Michael S. Hofman
Michael S. Hofman is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Cancer Research and Epidemiology, having authored 325 papers that have together received 11.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (169 papers), Radiopharmaceutical Chemistry and Applications (143 papers), Medical Imaging Techniques and Applications (75 papers), Prostate Cancer Diagnosis and Treatment (66 papers), Radiomics and Machine Learning in Medical Imaging (32 papers), Neuroendocrine Tumor Research Advances (32 papers), Lung Cancer Research Studies (25 papers) and Neuroblastoma Research and Treatments (25 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (6.5k citations), Pulmonary and Respiratory Medicine (7.1k citations), Oncology (3.0k citations), Radiation (878 citations) and Neurology (1.3k citations). Michael S. Hofman has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Rodney J. Hicks, Declan G. Murphy, Grace Kong, Nathan Lawrentschuk, Amir Iravani, Peter Eu, Price Jackson, Marlon Perera, John Violet and Shankar Siva. Their work appears in journals such as Journal of Clinical Oncology, Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, European Urology and British Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.